Iatrogenic Thyrotoxicosis. Causal Circumstances, Pathophysiology and Principles of Treatment. Review of the Literature

References

• Barclay M. L., Brownlie B. E. W., Turner J. G., Wells J. E. Lithium associated thyrotoxicosis : a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol, 1994, 40: 759-764, 1994.
   PubMed Web of Science ®Google Scholar
• McDermott M. T., Burman K. D., Hofeldt F. D., Kidd J. S. Lithium-associated thyrotoxicosis. Am J Med, 1986, 80: 1245-48.
   PubMed Web of Science ®Google Scholar
• Yassa, R., Sanders, A., Nastase, C., Camille, Y.: Lithium-induced thyroid disorders : a prevalence study. J Clin Psych, 1988, 49: 14-16.
   Google Scholar
• Berens S. C., Bernstein R. S., Robbins J., Wolff J. Antithyroid effects of lithium. J Clin Invest, 1970, 47: 1357-1367.
   Web of Science ®Google Scholar
• Brownlie E. W., Chambers S. T., Sadler W. A., Donald R. A. Lithium-associated thyroid disease, areport of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis. Aust NZ J Med, 1976, 6: 223-229.
   PubMedGoogle Scholar
• Emerson C. H., Dyson W. L., Utiger R. D. Serum thyrotropin and thyroxin concentrations in patients receiving lithium carbonate. J Clin Endocrinol Med, 1973, 289: 136-138.
   Google Scholar
• Wilson R., McKillop J. H., Crocket G. T., Pearson C., Jenkins C., Burns F., Burnett A. K., Thopson J. A. The effects of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol, 1991, 34: 357-361.
   PubMed Web of Science ®Google Scholar
• Weetman R., McGregor A. M., Lazarus J. H., Rees Smith B., Hall R. The enhancement of immunoglobulin synthesis by human lymphocytes with lithium. Clin 1mm Immunopath, 1982, 22: 400-401.
   PubMedGoogle Scholar
• Mizukami Y., Michigishi T., Nonomura A. Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis. J Clin Pathol, 1995, 48: 582-587.
   PubMed Web of Science ®Google Scholar
• Rabin P. L., Evans D. C. Exophtalmos and elevated thyroxine levels in association with lithium therapy. J Clin Psychiatry, 1981, 42: 398-400.
   PubMed Web of Science ®Google Scholar
• Franklin L. M. Thyrotoxicosis developing during lithium treatment: case report. NZ Med J, 1974, 79: 782.
   PubMed Web of Science ®Google Scholar
• Todd J., Jerram T. C. Thyrotoxicosis during lithium treatment. Br J Clin Prac, 1978, 32: 201-203.
   PubMedGoogle Scholar
• Thompson C. J., Baylis P. H. Asymptomatic Graves’ disease during lithium therapy. Postgrad Med J, 1986, 62: 295-296.
   PubMed Web of Science ®Google Scholar
• Turner J. G., Brownlie B. E. W., Rogers T. G. H. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis. Lancet, 1976, i : 614-615.
   Web of Science ®Google Scholar
• Vialettes B., Guillerand M. A., Viens P., Stoppa A. M., Baume D., Sauvan R., Pasquier J., San Marco M., Olive D., Maraninchi D. Incidence rate and risks factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies. Acta Endocrinol, 1993, 129: 31-38.
   PubMedGoogle Scholar
• Atkins M., Mier J., Demchak P., Robert N., Parkinson D., Kaplan M. Thyroid dysfunction following IL-2 therapy. Proc Am Soc Clin Oncol, 1990, 9: 186.
   Google Scholar
• Schwartentruber D. J., White de Zweig M. H., Weintraub B. D., Rosenberg S. A. Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer, 1991, 68: 2384-2390.
   PubMed Web of Science ®Google Scholar
• Pichert G., Jost L. M., Zöbeli L., Odermatt B., Pedio G., Stahel R. A. Thyroiditis after treatment with interleukin-2 and interferon α-2a. Br J Cancer, 1990, 62: 100-104.
   PubMed Web of Science ®Google Scholar
• Kasuga Y., Matsubayashi S., Akasu F., Miller N., Jamieson C., Volpe R. Effects of recombinant human interleukin-2 and tumor necrosis factor-α with or without interferon-γ on human thyroid tissues from patients with Graves’ disease and from normal subjects xenografted into nude mice. J Clin Endocrinol Metab, 1991, 72: 1296-1301.
   PubMed Web of Science ®Google Scholar
• Preziati D., La Rosa L., Covini G. Autoimmunity and thyroid function in patients with chronic active hepatitis treated by recombinant interferon alpha-2a. Eur J Endocrinol, 1995, 132: 587-593.
   PubMed Web of Science ®Google Scholar
• Roti E., Minelli R., Giuberti T., Marchelli S., Schianchi C., Gardini E., Salvi M., Fiaccadori F., Ugolotti G., Neri T. M., Braverman L. E. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon alpha. Am J Med, 1996, 101: 482-487.
   PubMed Web of Science ®Google Scholar
• Guerin V., Todd I., Hammondi L. J., Bottazzo G. F. Suppression of HLA class II expression on thyrocytes by interferonalpha. Clin Exp Immunol, 1990, 79: 341-345.
   PubMed Web of Science ®Google Scholar
• Yamazaki K., Kanaji Y., Shizumz K. Reversible inhibition by interferon alpha and beta of 1251 incorporation and thyroid hormone release by human thyroid follicules in vitro. J Clin Endocrinol Metab, 1993, 77: 1439-1441.
   PubMed Web of Science ®Google Scholar
• Jacobs E. L., Clare-Salzler M. J., Chopra I. J., Figlin R. A. Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha. J Immunother, 1991, 10: 448-455.
   PubMed Web of Science ®Google Scholar
• Weetman A. P., McGregor A. M. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev, 1994, 15: 788-830.
   PubMed Web of Science ®Google Scholar
• Koh L. K. H., Greespan F. S., Yeo P. P. B. Interferon alpha induced thyroid dysfunction: three clinical presentations and review of the literature. Thyroid, 1997, 7: 891-896.
   PubMed Web of Science ®Google Scholar
• Leckie R. G., Buckner A. B., Bornemann M. Seat belt-related thyroiditis documented with thyroid Tc-99m pertechnetate scans. Clin Nucl Med, 1992, 17: 859-860.
   PubMed Web of Science ®Google Scholar
• Blum M., Schloss M. F. Martial arts thyroiditis (letter to the editor). N Engl J Med, 1984, 311: 199.
   PubMed Web of Science ®Google Scholar
• Call R. A., Cohen K. L. Transient thyroiditis due to surgical trauma. Am J Med, 1993, 95: 546-548.
   PubMed Web of Science ®Google Scholar
• Kobayachi A., Kuma K., Matsuzuka F., Hirai K., Fukata S., Sugawara M. Thyrotoxicosis after needle aspiration of thyroid cyst. J Clin Endocrinol Metab, 1992, 75: 21-24.
   PubMed Web of Science ®Google Scholar
• Walfisch P., Caplan D., Rosen I. B. Postparathyroidectomy transient thyrotoxicosis. J Clin Endocrinol Metab, 1992, 75: 224-227.
   PubMed Web of Science ®Google Scholar
• Carney J. A., Moore S. B., Northcutt R. C., Woolner L. B., Stillwell G. K. Palpation thyroiditis (multifocal granulomatous folliculitis). Am J Clin Pathol, 1975, 64: 639-647.
   PubMed Web of Science ®Google Scholar
• Kay T. W. H., d’Emden M. C., Andrews J. T., Martin F. I. R. Treatment of non toxic multinodular goiter with radioactive iodine. AM J Med, 1988, 84: 19-22.
   PubMed Web of Science ®Google Scholar
• Huysmans D. A. K. C., Hermus R. M. M., Édelbroeck M. A. L., Tjabbes T., Oostdiik A., Ross A., Corstens F. H. M., Kloppenborg P. W. C. Autoimmune hyperthyroidism occuring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid, 1997, 7: 535-539.
   PubMed Web of Science ®Google Scholar
• Nygaard B., Faber J., Veje A., Hegedus L., Hansen J. M. Transitionof nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Thyroid, 1999, 9: 477-481.
   PubMed Web of Science ®Google Scholar
• Nygaard B., Knudsen J. H., Veje A., Hegedus L., Hansen J. E. M. Thyrotropin receptor antibodies and Graves’ disease, a side-effect of 131I treatment in patients with non toxic goiter. J Clin Endocrinol Metab, 1997, 82: 2926-2930.
   PubMed Web of Science ®Google Scholar
• Studer H., Peter H. J., Gerber H. Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular growth. Endocr Rev, 1989, 10: 125-129.
   PubMed Web of Science ®Google Scholar
• Tonacchera M., Chiovato R., Pinchera A., Agretti P., Fiore E., Cetani F., Rocchi R., Viancava P., Miccoli P., Vitti P. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary adenoma. J Clin Endocrinol Metab, 1998, 83: 492-498.
   PubMed Web of Science ®Google Scholar
• McGregor A. M., McLachan S. M., Smith B. R., Hall R. Effect of irradiation on the thyroid-autoantibody production. Lancet, 1979, ii: 442-444.
   Google Scholar
• Weetman A. P. Autoimmune thyroiditis: predisposition and pathogenesis. Clin Endocrinol, 1992, 36: 307-323.
   PubMed Web of Science ®Google Scholar
• Kay T., Heyma P., Harrisson L., Martin F. I. R. Graves’ disease induced by radioactive iodine. Ann Intern Med, 1987, 107: 857-858.
   PubMed Web of Science ®Google Scholar
• Fachnie J. D., Rao S. D. Painless thyroiditis with hyperthyroidism following external irradiation of the neck. Henry Ford Hosp Med J, 1980, 28: 149-151.
   PubMedGoogle Scholar
• Mortimer R. H., Hill G. E., Gallican J. P., Brandsen A. I., Tyack S. A., Roeser H. P. Hypothyroidism and Grves’ disease after mantle irradiation: a follow-up study. Aust NZ J Med, 1986, 16: 347-351.
   PubMedGoogle Scholar
• Wasnich R. D., Grumet F. C., Payne R. O., Kriss J. P. Ophtalmopathy following external neck irradaition for non thyroidal neoplastic disease. J Clin Endocrinol Metab, 1973, 37: 304-308.
   Web of Science ®Google Scholar
• McGregor A. M., McLachlan S. M., Rees Smith B., Hall R. Effect of irradiation on thyroid autoantibody production. Lancet, 1979, ii: 442-445.
   Google Scholar
• Rose E., Sanders T. P., Webbir W. L., Hines R. C. Occult factitial thyrotoxicosis. Ann Intrenn Med, 1969, 71: 309-313.
   PubMed Web of Science ®Google Scholar
• Greer M. A. Thyrotoxicosis of extrathyroid origin. In: Ingbar S. H., Braverman L. E. (eds.), Werner’s The Thyroid, ed 5. J. B. Lippincott Co, Philadelphia, p. 1120, 1986.
   Google Scholar
• Rogers H. M. The cardiovascular manifestations of induced thyrotoxicosis; report of two cases. Ann Intern Med, 1947, 26: 914-918.
   PubMed Web of Science ®Google Scholar
• Cohen J. H., Ingbar S. H., Braverman L. E. Thyrotoxicos due to ingestion of excess thyroid hormone. Endocr Rev, 1989, 10: 113-124.
   PubMed Web of Science ®Google Scholar
• Siegenbeek Van Heulekom L. H., der Kinderen P. J., Vingerheods A. C. M. Plasmapheresis in L-thyroxine intoxication. Plasma Therapy, 1980, 1: 33-38.
   Google Scholar
• Ohno F., Miyoshi K. Clinical observations on thyreoidismus medicamentosus due to weight reducing pills in Japan. Endocrinol Jpn, 1971, 18: 321-325.
   PubMedGoogle Scholar
• Hedberg C. W., Fishbein D. B., Janssen R. S., Meyers B., MacMillen J. M., MacDonald K. L., White K. E., Huss L. J., Hurwitz E. S., Farhie J. R., Simmons J. L., Braverman L. E., Ingbar S. H., Schonberger L. B., Osterholm M. T. An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef. N Engl J Med, 1897, 316: 993-998.
   Web of Science ®Google Scholar
• Kinney J. S., Hurwitz E. S., Fishbein D. B., Woolf P. D., Pinsky P. F., Lawrence D. N., Anderson L. J., Holmes J. P., Wilson C. K., Loschen D. J., Nordlund H. M., Oldfather J., Rodey G. E., Stoesz P. A., Schoenberger L. B. Community outbreak of thyrotoxicosis: epidemiology, immunogenetic characteristics, and long-term outcome. Am J Med, 1987, 84: 10-18.
   Web of Science ®Google Scholar
• Stange W. F., Henske J. A. Accidental ingestion of poisons. J Pediatr, 1955, 47: 470-479.
   PubMed Web of Science ®Google Scholar
• Riggs D. S., Man E. B., Winkler A. W. Serum iodine of euthyroid subject treated with dessicated thyroid. J Clin Invest, 1945, 24: 722-726.
   PubMed Web of Science ®Google Scholar
• Bhasin S., Wallace W., Lawrence J. B., Lesch M. Sudden death associated with thyroid hormone abuse. Am J Med, 1981, 71: 887-889.
   PubMed Web of Science ®Google Scholar
• Veltri J. C., Litovitz T. L. 1983 annual report of the american association of poison control centers national data collection system. Am J Emer Med, 1983, 2: 420-431.
   Web of Science ®Google Scholar
• Gorman R. L., Chamberlain J. M., Rose S. R. Massive levothyroxine overdose : high anxiety- low toxicity. Pediatrics, 1988, 82: 666-670.
   PubMed Web of Science ®Google Scholar
• May M. E., Mintz P. D., Lowry P., Geller R., Curnow R. T. Plasmapheresis in thyroxine overdose: a case report. J Toxicol Clin Toxicol, 1984, 20: 517-519.
   Web of Science ®Google Scholar
• Von Hofe S., Young R. L. Thyrotoxicosis after a single ingestion of levothyroxine. JAMA, 1977, 237: 1361-1362.
   PubMed Web of Science ®Google Scholar
• Gerard P., Malvaux P., de Visscher M. Accidental poisoning with thyroid extract treated by exchange transfusion. Arch Dis Child, 1972, 47: 980-982.
   PubMed Web of Science ®Google Scholar
• Nyström E., Lindstedt G., Lundberg P. A. Minor signs and symptoms of toxicity in a young woman in spite of massive thyroxine ingestion. Acta Med Scand, 1980, 207: 135-137.
   PubMedGoogle Scholar
• Dahlberg P. A., Karlsson F. A., Wide L. Triiodothyroxine intoxication. Lancet, 1979, ii: 700-702.
   Google Scholar
• Mariotti S., Martino E., Cupini C., Lari R., Giani C., Baschieri L., Pinchera A. Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. N Engl J Med, 1982, 307: 410-415.
   PubMed Web of Science ®Google Scholar
• Chopra I. J., Solomon D. H., Chopra U., Wu S. Y., Fisher D. A., Nakamura Y. Pathways of metabolism of thyroid hormones. Recent Prog Horm Res, 1978, 34: 521-567.
   PubMedGoogle Scholar
• Chopra I. J., Van Herle A. J., Korenman S. G., Viosca S., Younai S. Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis. J Clin Endocr Metah, 1995, 80: 2178-2180.
   PubMed Web of Science ®Google Scholar
• Berkner P. D., Starkman H., Person N. Acute L-thyroxine overdose; therapy with sodium ipodate: evaluation of clinical and physiologic parameters. J Emerg Med, 1991. 9: 129-131.
   PubMedGoogle Scholar
• Green W. L. Effect of drugs on thyroid function. In: Wy S. Y. (ed.). Thyroid hormone metabolism. Boston : Blackwell; 239-265, 1991.
   Google Scholar
• DeGroot L. J., Rue P. A. Roentgenographic contrats agents inhibit triiodothyronine binding to nuclear receptors in vitro. J Clin Endocrinol Metab, 49: 538-542, 1979.
   Web of Science ®Google Scholar
• Wolff J., Chaikoff I. L. Plasma inorganic iodide as homeostatic regulator of thyroid function. J Biol Chem, 1949, 174: 555-568.
   Web of Science ®Google Scholar
• Wolff J., Chaikoff I. L., Goldberg R. C. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology, 1949, 45: 504-510.
   PubMed Web of Science ®Google Scholar
• Fradkin J. E., Wolff J. Iodide-induced thyrotoxicosis. Medicine, 1983, 62: 1-20.
   PubMed Web of Science ®Google Scholar
• Martins L. M., Lima N., Knobel M. Natural course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area. A 5-year follow-up. J Endocrinol Invest, 1989, 12: 329-336.
   PubMed Web of Science ®Google Scholar
• London W. T., Vought R. L., Brown F. A. Bread-a dietary source of large quantities of iodine. N Engl J Med, 1965, 273: 381-383.
   PubMed Web of Science ®Google Scholar
• Lavelle K. J., Doldens D. J., Plert S. A. Iodine absorption in burn patients treated topically with povidone-iodine. Clin Pharmacol Ther, 1975, 17: 355-357.
   PubMed Web of Science ®Google Scholar
• Ross D. S. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab N Amer, 1998, 27: 169-185.
   PubMed Web of Science ®Google Scholar
• Leger F. A., Beaulieu J., Malinsky M., Chomette G., Savoie J. Therapeutic aspects of iodine-induced thyrotoxicosis. Ann Endocrinol, 1977, 38: 86A.
   Web of Science ®Google Scholar
• Harjai K. J., Licata A. A. Effects of Amiodarone on thyroid function. (Review). Ann Intern Med, 1997, 126: 63-73.
   PubMed Web of Science ®Google Scholar
• Reiffel J. A., Estes N. A., Waldo A. L., Prystowsky E. N., DiBianco R. A consensus report on antiarrhythmic drug use. (Review) Clin Cardiol, 1994, 17: 103-106.
   PubMed Web of Science ®Google Scholar
• Ceremuzynski L., Kleczar E., Krzeminska-Pakula M., Kuch J., Nartowicz E., Smielak-Korombel J., Dyduszynski A., Maciejewicz J., Zaleska T., Lazarczyk-Kedzia E., Motyka J., Paczkowska B., Sczaniecka O., Yusuf S. Effects of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol, 1992, 20: 1056-1062.
   PubMed Web of Science ®Google Scholar
• Chatterjee K. Amiodarone in chronic heart failure. (Editorial). J Am Coll Cardiol, 1989, 14: 1775-1776.
   PubMed Web of Science ®Google Scholar
• Albert S. G., Alves L. E., Rose E. P. Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol, 1987, 9: 175-183.
   PubMed Web of Science ®Google Scholar
• Nademanee K., Piwonka R. W., Singh B. N., Hershman J. M. Amiodarone and thyroid function. (Review). Prog Cardiovasc Dis, 31: 427-437, 1989.
   Web of Science ®Google Scholar
• Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, an anti-anginal drug with a new biological profile. Arzneimittelforschung, 1968, 18: 1408-1417.
   PubMed Web of Science ®Google Scholar
• Roti E., Vagenakis A. G.: Effect of excess iodide: clinical aspects. In: Braveman L. E., Utiger R. D. (eds.). Werner and Ingbar’s The Thyroid. A fundamental and clinical text. Philadelphia, J. B. Lippincott Company, 1991, pp. 390-402.
   Google Scholar
• Rao R. H., McCready V. R., Spathis G. S. Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab, 1986, 62: 563-568.
   PubMed Web of Science ®Google Scholar
• Figce H. L., Figge J. The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations. J Clin Pharmacol, 1990, 30: 588-595.
   PubMed Web of Science ®Google Scholar
• Broekhuysen J., Laruel R, Sion R. Recherches dans la série des benzofuranes XXXVII. Etude comparée du transit et du métabolisme de l’amiodarone chez diverses espèces animales et chez l’homme. Arch Int Pharmacodyn Ther, 1969, 177: 340-359.
   PubMedGoogle Scholar
• Singh B. N. Amiodarone: historical development and pharmacology profiles. (Review). Am Heart J, 1983, 106: 788-797.
   PubMed Web of Science ®Google Scholar
• Lombardi A., Martino E., Braverman L. E. Amiodarone and the thyroid. Thyroid Today, 1990, 13: 1-7.
   Google Scholar
• Martino E., Aghini-Lombardi F., Macchia E. Amiodarone-induced thyrotoxicosis. Italian Journal of medecine, 1986, 2: 15-20.
   Google Scholar
• Mehra A., Widerhorn J., Lopresti J., Rahimtoola S. H. Amiodarone-induced hyperthyroidism: thyroidectomy under local anesthesia. Am Heart J, 1991, 122: 1160-1161.
   PubMed Web of Science ®Google Scholar
• Martino E., Aghini-Lombardi F., Mariotti S., Bartalena L., Braverman L. E., Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horn Res, 1987, 26: 158-171.
   PubMedGoogle Scholar
• Meurisse M., Hamoir E., D’Silva M., Joris J., Hennen G. Amiodarone-induced thyrotoxicosis : is there a place for surgery? World J Surg. 1993, 17: 622-627.
   PubMed Web of Science ®Google Scholar
• Georges J. L., Normand J. P., Lenormand M., Schwob J. Life-threatening thyrotoxicosis induced by amiodarone in patients with benign heart disease. Eur Heart J, 1992, 13: 129-132.
   PubMed Web of Science ®Google Scholar
• Hauptman P. J., Fyfe B., Mechanick J., Lansman S., Gass A. Fatal hyperthyroidism after amiodarone treatment and total lymphoid irradiation in a heart transplant recipient. J Heart Lung Transplant, 1993, 12: 513-516.
   PubMed Web of Science ®Google Scholar
• Leger A. F., Massin J. P., Laurent M. F., Vincens M., Auriol M., Helal O. B., Chomette G., Savoie J. C. Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases. Eur J Clin Invest, 1984, 14: 449-455.
   PubMed Web of Science ®Google Scholar
• Peche R., Abramowicz M., Unger J. Failure to respond to dexamethasone with fatal consequences, after initial response to multidrug treatment in a case of amiodarone-associated thyrotoxicosis. (Review). Am J Med, 1992, 93: 702-703.
   PubMed Web of Science ®Google Scholar
• Broussolle C., Ducottet X., Martin C., Barbier Y., Bornet H., Noel G., Orgiazzi J. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal glands. J Endocrinol Invest, 1989, 12: 37-42.
   PubMed Web of Science ®Google Scholar
• Hennen G., Mary-Rabine L., Meurisse M. Hyperthyroidies sévères induites par l’iode: une urgence chirurgicale. Rev Med Liège, 1992, 47: 237-244.
   PubMedGoogle Scholar
• Sogol P. B., Hershman J. M., Reed A. W., Dillman W. H. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5’-monodeiodination in rats. Endocrinology, 1983, 113: 1464-1469.
   PubMed Web of Science ®Google Scholar
• Bartalena L., Brogioni S., Grasso L., Bogazzi F., Burelli A., Martino E. J. Clin. Treatment of amiodarone induced thyrotoxicosis, a difficult challenge : results of a prospective study. Endocrinol Metab, 1996, 81: 2930-2933.
   Google Scholar
• Smyrk T. C., Goellner J. R., Brennan M. D., Carney J. A. Pathology of the thyroid gland in amiodarone-associated thyrotoxicosis. Am J Surg Pathol, 1987, 11: 197-202.
   PubMed Web of Science ®Google Scholar
• Bartalena L., Grasso L., Brogioni S., Bogazzi F., Burelli A., Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab, 1994, 78: 423-427.
   PubMed Web of Science ®Google Scholar
• Bogazzi F., Bartalena L., Brogioni S., Mazzeo S., Vitti P., Burelli A., Bartolozzi C., Martino E. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid, 1997, 7: 541-545.
   PubMed Web of Science ®Google Scholar
• Hamoir E., Meurisse M., Defechereux T., Joris J., Vivario J., Hennen G. Surgical management of amiodarone-associated thyrotoxicosis : too risky or too effective? World J Surg, 1998, 22: 537-543.
   PubMed Web of Science ®Google Scholar
• Newman C. M., Price A., Davies D. W., Gray T. A., Weetman A. P. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart, 1998, 79: 121-127.
   PubMed Web of Science ®Google Scholar
• Brennan M. D., van Heerden J. A., Carney J. A. Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management. Surgery, 1987, 102: 1062-1069.
   PubMed Web of Science ®Google Scholar
• Farwell A. P., Abend S. L., Huang S. K., Patwardhan N. A., Braverman L. E. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA, 1990, 263: 1526-1528.
   PubMed Web of Science ®Google Scholar
• Donaghue K. C., Clarke P., Hooper M. J. Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis. Med J Aust, 1985, 142: 594-596.
   PubMed Web of Science ®Google Scholar
• Bronstein V., Coignard A., Gauthier D., Duret J. C., Droniou J. Thyrotoxicose sevère et surcharge iodée. A propos d’un cas d’évolution mortelle. Presse Med, 1992, 11: 2226.
   Google Scholar
• Rosenbaum M. B., Chiale P. A., Haedo A., Lazzari J. O., Elizari M. V. Ten years of experience with amiodarone. Am Heart J, 1983, 106: 957-964.
   PubMed Web of Science ®Google Scholar
• Reichert L. J., de Rooy H. A. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. Br Med J, 1989, 298: 1547-1548.
   PubMed Web of Science ®Google Scholar
• Boehm T. M., McLain J., Burman K. D., De Shazo R., Wartofsky L. Iodine treatment of iodine induced thyrotoxicosis. J Endocrinol Invest, 1980, 3: 419-424.
   PubMed Web of Science ®Google Scholar
• Kasai K., Suzuki H., Shimoda S. I. Effects of propylthiouracile and relatively small doses od iodine on early phase treatment of hyperhtyroidism? Acta Endocrinol (Copenh.), 1980, 93: 315-321.
   PubMedGoogle Scholar
• Johnson R. S., Moore W. G. Fatal aplastic anemia after treatment of thyrotoxicosis with potassium perchlorate. Br Med J, 1961, 1: 1369-1371.
   PubMed Web of Science ®Google Scholar
• Uzzan B., Pussard E., Leon A., Bekhechi D., Krivitzky A., Modigliani E., Perret G., Vassy R., Berdeaux A., Guidicelli J. F. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br J Clin Pharmacol, 1991, 31: 371-372.
   PubMed Web of Science ®Google Scholar
• Samaras K., Marel G. M. Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of proctated amiodarone-induced thyroiditis. Clin Endocrinol, 1996, 45: 365-368.
   PubMed Web of Science ®Google Scholar
• Mulligan D. C., McHenry C. R., Kinney W., Esselsteyn C. B. Amiodarone-induced thyrotoxocosis : clinical presentation and expanded indications for thyroidectomy. Surgery, 1993, 114: 1114-1119.
   PubMed Web of Science ®Google Scholar
• Koblin D. D., Romanoff M. E., Martin D. E., Hensley F. A., Larach D. R., Stauffer R. A., Luck J. Anaesthetic management of the paturient receiving amiodarone. Anesthesiology, 1987, 66: 551-553.
   PubMed Web of Science ®Google Scholar